RSPO3 and breast cancer: Despite this, the relatively low expression of Wnt/β‐catenin target genes in RSPO3‐driven mammary tumors suggests that tumorigenesis driven by RSPO3 might be less reliant on Wnt/β‐catenin pathway activation.